Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
The DNA damage response (DDR) pathway and ARF function as barriers to cancer development. Although commonly regarded as operating independently of each other, some studies proposed that ARF is positively regulated by the DDR. Contrary to either scenario, we found that in human oncogene-transformed and cancer cells, ATM suppressed ARF protein levels and activity in a transcription-independent manner. Mechanistically, ATM activated protein phosphatase 1, which antagonized Nek2-dependent phosphorylation of nucleophosmin (NPM), thereby liberating ARF from NPM and rendering it susceptible to degradation by the ULF E3-ubiquitin ligase. In human clinical samples, loss of ATM expression correlated with increased ARF levels and in xenograft and tissue culture models, inhibition of ATM stimulated the tumour-suppressive effects of ARF. These results provide insights into the functional interplay between the DDR and ARF anti-cancer barriers, with implications for tumorigenesis and treatment of advanced tumours.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a tight regulatory network in human cancer models was reported, whereby ATM suppresses ARF levels and ARF acts as a secondary barrier to cancer progression when ATM is inactivated31”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [31]
In the citing paper
“DDR precedes ARF engagement, whose activation is detected at later stages of cancer progression and less frequently than DDR”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [31]
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Genomic instability — an evolving hallmark of cancer
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397
Self-citationActivation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Self-citationOncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
Self-citationAn Oncogene-Induced DNA Damage Model for Cancer Development
Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851
Self-citationTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Shilov, I. V., Seymour, S. L., Patel, A. A., Loboda, A., Tang, W. H., Keating, S. P., Hunter, C. L., Nuwaysir, L. M., & Schaeffer, D. A. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t600050-mcp200 · Cited by 1,298
Hickson, I., Zhao, Y., Richardson, C. J., Green, S. J., Martin, N. M. B., Orr, A. I., Reaper, P. M., Jackson, S. P., Curtin, N. J., & Smith, G. C. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2727 · Cited by 1,220
Stott, F. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5001 · Cited by 1,167
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J. (2001) · Nature · doi:10.1038/35071124 · Cited by 1,085
(1999) · PubMed · Cited by 1,030
Directed Proteomic Analysis of the Human Nucleolus
Andersen, J. S., Lyon, C. E., Fox, A. H., Leung, A. K. L., Lam, Y. W., Steen, H., Mann, M., & Lamond, A. I. (2002) · Current Biology · doi:10.1016/s0960-9822(01)00650-9 · Cited by 1,023
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009
Quantitative, High-Resolution Proteomics for Data-Driven Systems Biology
Cox, J., & Mann, M. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061308-093216 · Cited by 685
c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I
Grandori, C., Gomez-Roman, N., Felton-Edkins, Z. A., Ngouenet, C., Galloway, D. A., Eisenman, R. N., & White, R. J. (2005) · Nature Cell Biology · doi:10.1038/ncb1224 · Cited by 665
Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins
Ramirez, R. D., Sheridan, S., Girard, L., Sato, M., Kim, Y., Pollack, J., Peyton, M., Zou, Y., Kurie, J. M., DiMaio, J. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-3703 · Cited by 607
Divorcing ARF and p53: an unsettled case
Sherr, C. J. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1954 · Cited by 595
DNA damage signalling guards against activated oncogenes and tumour progression
Bartek, J., Bartkova, J., & Lukas, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210881 · Cited by 521
Itahana, K., Bhat, K. P., Jin, A., Itahana, Y., Hawke, D., Kobayashi, R., & Zhang, Y. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00431-3 · Cited by 432
DiTullio, R. A., Mochan, T. A., Venere, M., Bartkova, J., Sehested, M., Bartek, J., & Halazonetis, T. D. (2002) · Nature Cell Biology · doi:10.1038/ncb892 · Cited by 407
Self-citationNonlinear Fitting Method for Determining Local False Discovery Rates from Decoy Database Searches
Tang, W. H., Shilov, I. V., & Seymour, S. L. (2008) · Journal of Proteome Research · doi:10.1021/pr070492f · Cited by 356
Up-regulation of Bcl-2 Homology 3 (BH3)-only Proteins by E2F1 Mediates Apoptosis
Hershko, T., & Ginsberg, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312866200 · Cited by 322
The combined status of ATM and p53 link tumor development with therapeutic response
Jiang, H., Reinhardt, H. C., Bartkova, J., Tommiska, J., Blomqvist, C., Nevanlinna, H., Bartek, J., Yaffe, M. B., & Hemann, M. T. (2009) · Genes & Development · doi:10.1101/gad.1815309 · Cited by 304
Li, Z., Adams, R. M., Chourey, K., Hurst, G. B., Hettich, R. L., & Pan, C. (2012) · Journal of Proteome Research · doi:10.1021/pr200748h · Cited by 302
Nucleolar Arf Tumor Suppressor Inhibits Ribosomal RNA Processing
Sugimoto, M., Kuo, M.-L., Roussel, M. F., & Sherr, C. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00057-1 · Cited by 273
Functional and dynamic aspects of the mammalian nucleolus
Scheer, U., & Benavente, R. (1990) · BioEssays · doi:10.1002/bies.950120104 · Cited by 273
Sato, M., Vaughan, M. B., Girard, L., Peyton, M., Lee, W., Shames, D. S., Ramirez, R. D., Sunaga, N., Gazdar, A. F., Shay, J. W., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2521 · Cited by 263
Oncogene-induced senescence: the bright and dark side of the response
Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.07.013 · Cited by 257
Self-citationDeregulated Overexpression of hCdt1 and hCdc6 Promotes Malignant Behavior
Liontos, M., Koutsami, M., Sideridou, M., Evangelou, K., Kletsas, D., Levy, B., Kotsinas, A., Nahum, O., Zoumpourlis, V., Kouloukoussa, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2837 · Cited by 217
Self-citationNucleophosmin Is Required for DNA Integrity and p19Arf Protein Stability
Colombo, E., Bonetti, P., Lazzerini Denchi, E., Martinelli, P., Zamponi, R., Marine, J.-C., Helin, K., Falini, B., & Pelicci, P. G. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.20.8874-8886.2005 · Cited by 214
Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases
Colombo, E., Alcalay, M., & Pelicci, P. G. (2011) · Oncogene · doi:10.1038/onc.2010.646 · Cited by 210
N-terminal polyubiquitination and degradation of the Arf tumor suppressor
Kuo, M.-L., den Besten, W., Bertwistle, D., Roussel, M. F., & Sherr, C. J. (2004) · Genes & Development · doi:10.1101/gad.1213904 · Cited by 208
Karakaidos, P., Taraviras, S., Vassiliou, L. V., Zacharatos, P., Kastrinakis, N. G., Kougiou, D., Kouloukoussa, M., Nishitani, H., Papavassiliou, A. G., Lygerou, Z., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63393-7 · Cited by 180
Self-citationNek2 kinase in chromosome instability and cancer
Hayward, D. G., & Fry, A. M. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.06.017 · Cited by 178
Geradts, J., Kratzke, R. A., Niehans, G. A., & Lincoln, C. E. (1995) · PubMed · Cited by 168
Involvement of E2F transcription factor family in cancer
Tsantoulis, P. K., & Gorgoulis, V. G. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.005 · Cited by 163
Self-citationTranscription-independent ARF regulation in oncogenic stress-mediated p53 responses
Chen, D., Shan, J., Zhu, W.-G., Qin, J., & Gu, W. (2010) · Nature · doi:10.1038/nature08820 · Cited by 160
Self-citationDynamic targeting of protein phosphatase 1 within the nuclei of living mammalian cells
Trinkle-Mulcahy, L., Sleeman, J. E., & Lamond, A. I. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.23.4219 · Cited by 160
Kamijo, T., van de Kamp, E. H., Chong, M. J., Zindy, F., Diehl, J. A., Sherr, C. J., & McKinnon, P. J. (1999) · PubMed · Cited by 140
Takubo, K., Ohmura, M., Azuma, M., Nagamatsu, G., Yamada, W., Arai, F., Hirao, A., & Suda, T. (2008) · Cell stem cell · doi:10.1016/j.stem.2007.10.023 · Cited by 122
Kilpivaara, O., Bártková, J., Eerola, H., Syrjäkoski, K., Vahteristo, P., Lukas, J., BLOMQVIST, C. P., Holli, K., Heikkilä, P., Sauter, G., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20638 · Cited by 116
Tautomycetin Is a Novel and Specific Inhibitor of Serine/Threonine Protein Phosphatase Type 1, PP1
Mitsuhashi, S., Matsuura, N., Ubukata, M., Oikawa, H., Shima, H., & Kikuchi, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5596 · Cited by 114
Gorgoulis, V. G., Zacharatos, P., Kotsinas, A., Liloglou, T., Kyroudi, A., Veslemes, M., Rassidakis, A., Halazonetis, T. D., Field, J. K., & Kittas, C. N. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65690-8 · Cited by 113
Self-citationp53 activates ICAM‐1 (CD54) expression in an NF‐κB‐independent manner
Gorgoulis, V. G., Zacharatos, P., Kotsinas, A., Kletsas, D., Mariatos, G., Zoumpourlis, V., Ryan, K. M., Kittas, C. N., & Papavassiliou, A. G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg157 · Cited by 112
Self-citationLee, C., Smith, B. A., Bandyopadhyay, K., & Gjerset, R. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1759 · Cited by 109
TopBP1 functions with 53BP1 in the G1 DNA damage checkpoint
Cescutti, R., Negrini, S., Kohzaki, M., & Halazonetis, T. D. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.238 · Cited by 107
Self-citationKhan, S. H., Moritsugu, J., & Wahl, G. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3266 · Cited by 103
Eymin, B., Claverie, P., Salon, C., Leduc, C., Col, E., Brambilla, E., Khochbin, S., & Gazzeri, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02240-05 · Cited by 103
Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins
Sideridou, M., Zakopoulou, R., Evangelou, K., Liontos, M., Kotsinas, A., Rampakakis, E., Gagos, S., Kahata, K., Grabusic, K., Gkouskou, K., et al. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201108121 · Cited by 98
Self-citationLessard, F., Morin, F., Ivanchuk, S. M., Langlois, F., Stefanovsky, V. Y., Rutka, J. T., & Moss, T. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.03.015 · Cited by 95
Zacharatos, P., Kotsinas, A., Evangelou, K., Karakaidos, P., Vassiliou, L., Rezaei, N., Kyroudi, A., Kittas, C., Patsouris, E., Papavassiliou, A. G., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1582 · Cited by 83
Self-citationDi Micco, R., Cicalese, A., Fumagalli, M., Dobreva, M., Verrecchia, A., Pelicci, P. G., & di Fagagna, F. D. (2008) · Cell Cycle · doi:10.4161/cc.7.22.7152 · Cited by 76
Essential Role of the B23/NPM Core Domain in Regulating ARF Binding and B23 Stability
Enomoto, T., Lindström, M. S., Jin, A., Ke, H., & Zhang, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602788200 · Cited by 74
A Novel ATM-Dependent Pathway Regulates Protein Phosphatase 1 in Response to DNA Damage
Tang, X., Hui, Z.-G., Cui, X.-L., Garg, R., Kastan, M. B., & Xu, B. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01711-07 · Cited by 67
Honrado, E., Osorio, A., Palacios, J., Milne, R. L., Sánchez, L., Díez, O., Cazorla, A., Syrjakoski, K., Huntsman, D., Heikkilä, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.3698 · Cited by 65
Guanine nucleotide depletion inhibits pre-ribosomal RNA synthesis and causes nucleolar disruption
Huang, M., Ji, Y., Itahana, K., Zhang, Y., & Mitchell, B. S. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.03.025 · Cited by 60
Limited Role of Murine ATM in Oncogene-Induced Senescence and p53-Dependent Tumor Suppression
Efeyan, A., Murga, M., Martinez-Pastor, B., Ortega-Molina, A., Soria, R., Collado, M., Fernandez-Capetillo, O., & Serrano, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005475 · Cited by 58
Nucleolar Nek11 Is a Novel Target of Nek2A in G1/S-arrested Cells
Noguchi, K., Fukazawa, H., Murakami, Y., & Uehara, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404104200 · Cited by 55
Liontos, M., Niforou, K., Velimezi, G., Vougas, K. N., Evangelou, K., Apostolopoulou, K., Vrtěl, R., Damalas, A. F., Kontovazenitis, P., Kotsinas, A., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081160 · Cited by 53
Self-citationLin, C. Y., Tan, B. C., Liu, H., Shih, C.-J., Chien, K., Lin, C., & Yung, B. Y. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-03-0239 · Cited by 46
ATM activity contributes to the tumor-suppressing functions of p14ARF
Li, Y., Wu, D., Chen, B., Ingram, A. J., He, L., Liu, L., Zhu, D., Kapoor, A., & Tang, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207957 · Cited by 45
Churchman, M. L., Roig, I., Jasin, M., Keeney, S., & Sherr, C. J. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002157 · Cited by 42
p53 Binds to and Is Required for the Repression of Arf Tumor Suppressor by HDAC and Polycomb
Zeng, Y., Kotake, Y., Pei, X.-H., Smith, M. D., & Xiong, Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3483 · Cited by 39
Brooks, D. G., James, R. M., Patek, C. E., Williamson, J., & Arends, M. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204309 · Cited by 35
Depletion of Guanine Nucleotides Leads to the Mdm2-Dependent Proteasomal Degradation of Nucleostemin
Huang, M., Itahana, K., Zhang, Y., & Mitchell, B. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3413 · Cited by 31
Vestey, S., Sen, C., Calder, C., Perks, C., Pignatelli, M., & Winters, Z. (2004) · Breast Cancer Research · doi:10.1186/bcr912 · Cited by 20
Selective requirement of H2B N-Terminal tail for p14ARF-induced chromatin silencing
Choi, J., Kim, H., Kim, K., Lee, B., Lu, W., & An, W. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr642 · Cited by 12
Induction of the human ARF protein by serum starvation.
Inoue, R., Asker, C., Klangby, U., Pisa, P., & Wiman, K. G. (1999) · PubMed · Cited by 12
Cited by
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Senescence and apoptosis: dueling or complementary cell fates?
Childs, B. G., Baker, D. J., Kirkland, J. L., Campisi, J., & van Deursen, J. M. (2014) · The EMBO Reports · doi:10.15252/embr.201439245 · Cited by 915
p21: a two-faced genome guardian.
Georgakilas, A. G., Martin, O. A., & Bonner, W. M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.02.001 · Cited by 489
Galanos, P., Vougas, K., Walter, D., Polyzos, A., Maya-Mendoza, A., Haagensen, E. J., Kokkalis, A., Roumelioti, F.-M., Gagos, S., Tzetis, M., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3378 · Cited by 308
Self-citation
Metadata
- Authors
- Velimezi, G., Liontos, M., Vougas, K., Roumeliotis, T., Bartkova, J., Sideridou, M., Dereli-Oz, A., Kocylowski, M., Pateras, I. S., Evangelou, K., Kotsinas, A., Orsolic, I., Bursac, S., Cokaric-Brdovcak, M., Zoumpourlis, V., Kletsas, D., Papafotiou, G., Klinakis, A., Volarevic, S., Gu, W., Bartek, J., Halazonetis, T. D., & Gorgoulis, V. G.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Biomedical Research Foundation of the Academy of Athens (GR)
- University of Geneva (CH)
- Danish Cancer Society (DK)
- National Hellenic Research Foundation (GR)
- National Centre of Scientific Research "Demokritos" (GR)
- Columbia University (US)
- Corresponding author
- Gorgoulis, Vassilis G.
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2013-07-14
- Volume
- 15
- Issue
- 8
- Pages
- 967-977
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2039467788
- Cited by
- 131
- References
- 75
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 7 · 2020: 9 · 2019: 6 · 2018: 14 · 2017: 11 · 2016: 28 · 2015: 14 · 2014: 20 · 2013: 5
- FWCI
- 11.95
- Type
- journal article
- Language
- en
- Update notices
- erratum (2013-10-01)
- Open access
- Licence
- cc-by
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- ATM kinase, DNA damage response, tumor suppression, protein phosphatase 1, NEK2, protein degradation, oncogene-transformed cells, carcinogenesis, ATM inhibition
- MeSH terms
- NIMA-Related Kinases, Animals, Carrier Proteins, Cell Cycle, Cell Line, DNA-Binding Proteins, HeLa Cells, Humans, Male, Neoplasms, Phosphorylation, Ribosomes, Transplantation, Heterologous, Signal Transduction, Gene Expression Regulation, Neoplastic, Protein Serine-Threonine Kinases, Cell Cycle Proteins, ADP-Ribosylation Factor 1, Tumor Suppressor Protein p14ARF, Ubiquitin-Protein Ligases, Cell Line, Tumor, Mice, Protein Stability, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.